Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

TL Whiteside - Cancer Immunology, Immunotherapy, 2014 - Springer
Regulatory T cells (Treg) play a key role in maintaining the balance of immune responses in
human health and in disease. Treg come in many flavors and can utilize a variety of …

Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer

X Liu, G Yan, B Xu, H Yu, Y An, M Sun - Frontiers in Immunology, 2022 - frontiersin.org
Background Macrophage infiltration is crucial for colorectal cancer (CRC) immunotherapy.
Detailed classification of macrophage subsets will facilitate the selection of patients suitable …

[HTML][HTML] Differential gene expression of tumor-infiltrating CD8+ T cells in advanced versus early-stage colorectal cancer and identification of a gene signature of poor …

R Saleh, VS Nair, SM Toor, RZ Taha… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
Background Cytotoxic CD8+ T cell-mediated response is the most important arm of adaptive
immunity, which dictates the capacity of the host immune response in eradicating tumor …

Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression

K Peng, Y Liu, S Liu, Z Wang, H Zhang, W He, Y Jin… - Cellular Oncology, 2024 - Springer
Purpose PIK3CA mutation or overexpression is associated with immunotherapy resistance
in multiple cancer types, but is also paradoxically associated with benefit of COX-2 inhibition …

Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity

H Yano, LP Andrews, CJ Workman, DAA Vignali - Immunology, 2019 - Wiley Online Library
Regulatory T (Treg) cells play a crucial role in maintaining self‐tolerance and resolution of
immune responses by employing multifaceted immunoregulatory mechanisms. However …

Immune checkpoints expression in MSI versus MSS colorectal cancers and their potential therapeutic implications.

NJ Llosa, F Housseau, EC Wick, L Hechenbleikner… - 2014 - ascopubs.org
3620 Background: Colorectal cancer (CRC) is divided into 2 groups based on genomic
differences: chromosomal instability (80%), and microsatellite instability (MSI)(20%). MSI …

Digital analysis and epigenetic regulation of the signature of rejection in colorectal cancer

VH Koelzer, L Sokol, S Zahnd, L Christe… - …, 2017 - Taylor & Francis
The immune system plays a pivotal role in the development and progression of colorectal
cancer (CRC). Tumor immune rejection has been previously linked to the activation of the …

The miRNA profile of inflammatory colorectal tumors identify TGF-β as a companion target for checkpoint blockade immunotherapy

B Bartlett, Z Gao, M Schukking, M Menor… - Frontiers in Cell and …, 2021 - frontiersin.org
Extrinsic factors such as expression of PD-L1 (programmed dealth-ligand 1) in the tumor
microenvironment (TME) have been shown to correlate with responses to checkpoint …

Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients

MA Al-Mterin, K Murshed, A Alsalman, A Abu-Dayeh… - BMC cancer, 2022 - Springer
There are different subsets of T regulatory cells (Tregs), orchestrating critical roles in the
regulation of anti-tumor immunity in colorectal cancer (CRC). In this study, we report that a …

RIG-I resists hypoxia-induced immunosuppression and dedifferentiation

C Engel, G Brügmann, S Lambing… - Cancer Immunology …, 2017 - AACR
A hypoxic tumor microenvironment is linked to poor prognosis. It promotes tumor cell
dedifferentiation and metastasis and desensitizes tumor cells to type-I IFN, chemotherapy …